POLLUX & amp; CASTOR Studies for Relapsed or Refractory Multiple Myeloma

Mark Wildgust, Vice President of Global Medical Affairs for Janssen Oncology gives an overview of the POLLUX/CASTOR studies, which looked at daratumumab in combination with lenalidomide plus dexametha... Author: ASCO2017 Added: 06/15/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts